Adam Walsh analyst ROTH

Currently out of the existing stock ratings of Adam Walsh, 80 are a BUY (85.11%), 12 are a HOLD (12.77%), 2 are a SELL (2.13%).

Adam Walsh

Work Performance Price Targets & Ratings Chart

Analyst Adam Walsh, currently employed at ROTH, has had 67.01% of price targets met with an average potential upside of 41.26%, reached in 397 days on average. Previously, Adam Walsh worked at ROTH MKM.

Adam Walsh has documented 180 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSM, Insmed at 15-Sep-2026.

Wall Street Analyst Adam Walsh

Analyst best performing recommendations are on VRTX (VERTEX PHARMACEUTICALS).
The best stock recommendation documented was for VRTX (VERTEX PHARMACEUTICALS) on 7/18/2017. The price target of $154 was fulfilled within 1 day with a profit of $21.84 (16.53%), with a performance score of 165.25.

Average potential price target upside

CNCE Concert Pharmaceuticals CORT Corcept Therapeutics INSM Insmed DRRX Durect RARE Ultragenyx ALDX Aldeyra The PHAS PhaseBio Pharmaceuticals VRTX Vertex Pharmaceuticals GLPG Galapagos NV ADR RETA Reata Pharmaceuticals ASND Ascendis Pharma AS FGEN FibroGen GLMD Galmed Pharmaceuticals Ltd PTGX Protagonist Therapeutics SAGE Sage Therapeutic VRNA Verona Pharma PLC ADR EQ Equillium BIOA BioAge Labs ALNY Alnylam Pharmaceuticals APLS Apellis Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-Nov-2020

$10

3 years 10 months 2 days ago
(19-Jan-2023)

0/3 (0%)

$6 (150.00%)

Buy Since 10-Aug-2020

$14

3 years 10 months 2 days ago
(19-Jan-2023)

0/2 (0%)

$8.11 (137.69%)

Buy Since 24-Jun-2019

$9

$25

3 years 10 months 2 days ago
(19-Jan-2023)

0/7 (0%)

$0.71 (8.56%)

Buy Since 04-Sep-2019

$11

$25

4 years 5 months 29 days ago
(23-May-2022)

0/5 (0%)

$6.9 (168.29%)

Buy Since 24-Jul-2017

$17

$17

4 years 5 months 29 days ago
(23-May-2022)

1/7 (14.29%)

$12.9 (314.63%)

115

Show more analysts

Stocks Adam Walsh covered previously. Scores are shown for active stocks only.

CNC Centene Corp VTVT vTv Therapeutics

Please expand the browser size to see the chart

Which stock is Adam Walsh most bullish on?

Potential upside of $56.67 has been obtained for INSM (INSMED)

Which stock is Adam Walsh most reserved on?

Potential downside of $10.94 has been obtained for EQ (EQUILLIUM)

What Year was the first public recommendation made by Adam Walsh?

On 2015
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?